drugset / Trial / NCT03135626

Comparison of The Success Rates of Four Different Pulpotomy Techniques

NCT03135626

Phase 3 Completed 38 enrolled Istanbul University
RandomizedParallel-groupDouble-blindTreatment

Summary

This randomized clinical trial was conducted to examine and compare the effectiveness of pulpotomy in primary molars treated with calcium silicate based materials including Biodentine and two different mineral trioxide aggregate (MTA) products (white ProRoot® MTA and MTA Plus®). Ferric sulfate pulpotomy was selected to represent the control group. 116 primary molars in 29 children were treated by pulpotomy and followed for a period of 24 months.

Timeline

Start
2013-03-15
Primary completion
2014-01-15
Completion
2016-02-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Biodentine Other / unclassified
Comparator Ferric Sulfate 20 % Dental Gel Unknown
Subject MTA Plus Other / unclassified
Subject ProRoot (Aggregate) Other / unclassified

Indications